Position in DXCM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$870,156
-$62,077 QoQ
Shares Held
13,856
-1.4% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.40%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026FORMULA GROWTH LTD holds $7,082,897 across 6 Medical Devices names. DXCM ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PODD |
Insulet Corp
|
12,029 | $2,524,165 | |
| 2 | PROF |
Profound Medical Corp.
|
241,138 | $1,562,574 | |
| 3 | TNDM |
Tandem Diabetes Care Inc
|
70,828 | $1,357,772 | |
| 4 | DXCM |
Dexcom Inc
This page
|
13,856 | $870,156 | |
| 5 | CBLL |
Ceribell, Inc.
|
31,000 | $568,230 | |
| 6 | TLSI |
TriSalus Life Sciences, Inc.
|
50,000 | $200,000 |
All Filings in DXCM
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $870,156 | 13,856 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $932,233 | 14,046 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,525,595 | 37,533 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $4,149,155 | 47,533 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $3,984,926 | 58,353 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $3,744,469 | 48,148 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,712,737 | 25,548 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,917,040 | 25,728 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,920,744 | 21,058 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,705,162 | 21,800 | Shares | Sole | 2024-02-13 | |
| No filing history on record for this holder in this stock. | ||||||